Congratulations to Sophia Johnson, PharmD, MPH, who has received an AHRQ F32 grant, Predictors, Use & Consequences of Biologics & Other Agents in Older IBD Patients.
The proposed research will analyze a cohort of 10,479 Medicare beneficiaries with IBD who are age 65 and above to address the following aims: (1) to examine clinical and socio-demographic predictors of anti-TNF use in older inflammatory bowel disease patients without contraindications to anti-TNF therapy, (2) to compare health and healthcare outcomes between anti-TNF users and anti-TNF non-users among older IBD patients without contraindications, and (3) to describe common treatment regimens in older IBD patients with contraindications. This research project will provide insight to refine the IBD quality measures that were recently released by the Center for Medicare and Medicaid Services.